Saltar al contenido
Merck

[Metabolism of 2,2',5,5'-tetrachlorobiphenyl (CB52) by rabbit liver microsomes].

Fukuoka igaku zasshi = Hukuoka acta medica (2009-07-11)
Chiho Ohta, Koichi Haraguchi, Yoshihisa Kato, Tetsuya Endo, Nobuyuki Koga
RESUMEN

Our preceding studies have reported that 2,2',5,5'-tetrachlorobiphenyl (tetraCB)(CB52) is mainly metabolized to 3-hydroxy (OH)-metabolite by phenobarbital (PB)-inducible cytochrome P450 (P450) isoforms such as CYP2B1 and CYP2B18. In this study, the metabolism of CB52 by liver microsomes of untreated and PB-treated rabbits was investigated. Rabbit liver microsomes produced mainly 3-OH- and 4-OH-metabolites (M-1 and M-2) at an equal extent and two other metabolites (M-3 and M-4) and also that phenobarbital (PB) treatment accelerated the formation of all these metabolites, M-3 was assumed to OH-tetraCB by GC-MS. Another metabolite, M-4, was determined to 3,4-diOH-CB52 by GC-MS and 1H-NMR. Addition of antiserum against CYP2B4, a constitutive and PB-inducible rabbit P450 isoform, to a microsomal incubation system resulted in almost complete inhibition of the formation of 3-OH-, 4-OH- and 3,4-diOH-metabolites. These results suggest that CYP2B4 plays an important role in CB52 metabolism in rabbit liver.

MATERIALES
Referencia del producto
Marca
Descripción del producto

Supelco
PCB nº 52, analytical standard
2,2′, 5,5′-Tetraclorobifenilo (IUPAC No. 52), BCR®, certified reference material